Miragen Therapeutics, Inc. Gains 26.35%

Wed 04 Mar 20 at 05:30 PM
Miragen Therapeutics, Inc. Gains 26.35%

Miragen Therapeutics, Inc. (MGEN:NASDAQ) shot up at $0.92, representing a gain of 26.3%. The stock got featured on our News Catalysts scanner on Thu 20 Feb 20 at 05:26 PM in the 'EARNINGS' category. From Tue 11 Feb 20, the stock recorded 35.71% Up Days and 40.00% Green Days

The stock spiked on Thu 30 Jan 20 at $2.27 with a volume of 27M+, and its share price has been moving sideways in recent weeks.

About Miragen Therapeutics, Inc. (MGEN:NASDAQ)

Miragen Therapeutics Inc is a clinical-stage biopharmaceutical company which engaged in discovering and developing proprietary RNA (Ribonucleic acid)-targeted therapeutics.